EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share

The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2025		2024		2025		2024
	(amounts in thousands, except per share data)
Numerator:
Net (loss) income attributable to common stockholders - Basic and Diluted	$	(4,774)	$	2,555	$	(11,923)	$	(10,803)

Denominator:
Weighted average common shares - Basic	32,524		33,016		32,434		33,728
Effect of diluted shares:
Share-based awards	—		42		—		—
Weighted average common shares - Diluteda	32,524		33,058		32,434		33,728

Net (loss) income per share attributable to common stockholders - Basic	$	(0.15)	$	0.08	$	(0.37)	$	(0.32)

Net (loss) income per share attributable to common stockholders - Diluted	$	(0.15)	$	0.08	$	(0.37)	$	(0.32)

(a) For the three months ended September 30, 2025 and the nine months ended September 30, 2025 and 2024, the effect of diluted shares was not included in the weighted average share calculation due to the Company’s net operating loss position.

Schedule of Antidilutive Securities

The following table represents the share-based awards that could potentially dilute net (loss) income per share attributable to common stockholders in the future that were not included in the computation of diluted net (loss) income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.


	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2025	2024	2025	2024
	(amounts in thousands)
Share-based awards	235	431	161	314

CROSS COUNTRY HEALTHCARE INC 10-Q